Clinical Trials
29 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT05257551 2026-04-02
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Tempus AI
Recruiting
NCT04894591 2026-02-27
SCLC
Jazz Pharmaceuticals
Completed
NCT05683977 2026-02-24
ARSENAL
AstraZeneca
Active not recruiting
NCT03782207 2026-01-08
IMreal
Hoffmann-La Roche
Active not recruiting
NCT04056247 2025-10-15
PROPHETIC
OncoHost Ltd.
Active not recruiting
NCT06826677 2025-06-24
ARAL
AstraZeneca
Completed
NCT05337163 2025-03-21
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Completed
NCT04510129 2025-03-12
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Recruiting
NCT06008353 2024-12-19
EDUR-BRA
AstraZeneca
Active not recruiting
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT04836975 2024-01-18
REVEAL
AstraZeneca
Completed
NCT03499678 2023-12-22
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
HKGepitherapeutics
Terminated
NCT04106167 2023-09-21
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Terminated
NCT05769504 2023-04-03
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
Power Life Sciences Inc.
Unknown
NCT03232593 2022-08-24
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Hoffmann-La Roche
Completed
NCT03425825 2022-01-26
Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
Bristol-Myers Squibb
Completed
NCT03911219 2021-10-05
CHAPLIN
iOMEDICO AG
Completed
NCT03505515 2021-09-14
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
Bristol-Myers Squibb
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT01040312 2019-05-23
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
Completed
NCT02715102 2017-08-21
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Pathway Genomics
Terminated
NCT02577627 2017-04-04
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
Optimata Ltd.
Unknown
NCT00883181 2017-03-15
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen
Completed
NCT01770665 2016-09-16
MiCK Assay
Pierian Biosciences
Terminated
NCT01037023 2015-04-15
Hycamtin PMS
GlaxoSmithKline
Completed
NCT01591512 2015-03-06
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
Fujirebio Diagnostics, Inc.
Terminated
NCT00997061 2014-02-03
SCOT
GlaxoSmithKline
Completed